866-997-4948(US-Canada Toll Free)

Anti-infective Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025

Published By :

Transparency Market Research

Published Date : Mar 2018

Category :

Drug Delivery

No. of Pages : 235 Pages

Anti-infective Drugs Market: Overview

This report studies the current as well as future prospects of the global anti-infective drugs market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of anti-infective drugs for pneumothorax and pleural effusion treatment as well as new players planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides overall information and data analysis of the global anti-infective drugs market with respect to the leading market segments based on type, indication, distribution channel, and region.

Based on type, the global anti-infective drugs market has been segmented into anti-bacterial drugs, anti-fungal drugs, and anti-viral drugs. In terms of indication, the market has been classified into pneumonia, methicillin-resistant Staphylococcus aureus (MRSA), sepsis, tuberculosis, dermatophytosis, aspergillosis, candidiasis, hepatitis virus infection, HIV infection, respiratory virus infection, and others. Based on distribution channel, the global anti-infective drugs market has been divided into hospital pharmacy, retail pharmacy, and online sales.

Each of the market segments has been extensively analyzed based on market related factors such as incidence and prevalence of pneumonia, methicillin-resistant Staphylococcus aureus (MRSA), sepsis, tuberculosis, dermatophytosis, aspergillosis, candidiasis, hepatitis virus infection, HIV infection, and respiratory virus infection. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the anti-infective drugs market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different regions. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global anti-infective drugs market.

Geographically, the global anti-infective drugs market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global anti-infective drugs market.

Key players operating in the global anti-infective drugs market are Merck & Co., Inc., Bayer AG, Pfizer, Inc., Gilead Sciences, GlaxoSmithKline plc, Novartis AG, Bristol-Myers Squibb, Sanofi, Allergen plc, F. Hoffman-La Roche Ltd., and Johnson and Johnson, among others.

The global anti-infective drugs market has been segmented as follows:

Global Anti-infective Drugs Market, by Type

  • Anti-bacterial Drugs
    • B-lactams
    • Quinolones
    • Macrolides
    • Tetracycline
    • Aminoglycoside
    • Others (sulfonamide, phenicols)
  • Anti-fungal Drugs
    • Azoles
    • Echinocandins
    • Polyenes
    • Others
  • Anti-viral Drugs

Global Anti-infective Drugs Market, by Indication

  • Pneumonia
  • Methicillin-resistant Staphylococcus Aureus (MRSA)
  • Sepsis
  • Tuberculosis
  • Dermatophytosis
  • Aspergillosis
  • Candidiasis
  • Hepatitis Virus Infection
  • HIV Infection
  • Respiratory Virus Infection
  • Others

Global Anti-infective Drugs Market, by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales

Global Anti-infective Drugs Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • U.K.
    • Rest of Europe
  • Asia Pacific
    • India
    • Japan
    • China
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Acronyms Used
2.3. Research Methodology

3. Executive Summary
3.1. Global Anti-infective Drugs Market Snapshot
3.2. Market Opportunity Map

4. Market Overview
4.1. Product Overview
4.2. Global Anti-infective Drugs Market Size (US$ Mn) Forecast, 2017–2025
4.3. Global Anti-infective Drugs Market Outlook
4.4. Key Industry Developments

5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Key Trends
5.6. Porter’s Analysis
5.7. Pipeline Analysis
5.8. Disease Prevalence
5.9. Key Brand Analysis

6. Global Anti-infective Drugs Market Analysis, by Type
6.1. Key Findings
6.2. Introduction
6.3. Anti-infective Drugs Market Value Share Analysis, by Type
6.4. Anti-infective Drugs Market Forecast, by Type
6.4.1. Global Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
6.4.1.1. B - Lactams
6.4.1.2. Quinolones
6.4.1.3. Macrolides
6.4.1.4. Tetracycline
6.4.1.5. Aminoglycoside
6.4.1.6. Others (Sulfonamide, Phenicols)
6.4.2. Global Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
6.4.2.1. Azoles
6.4.2.2. Echinocandins
6.4.2.3. Polyenes
6.4.2.4. Others
6.4.3. Global Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
6.5. Anti-infective Drugs Market Analysis, by Type
6.6. Anti-infective Drugs Market Attractiveness Analysis, by Type
6.7. Market Trends

7. Anti-infective Drugs Market Analysis, by Disease Indication
7.1. Key Findings
7.2. Introduction
7.3. Anti-infective Drugs Market Value Share Analysis, by Disease Indication
7.4. Anti-infective Drugs Market Forecast, by Disease Indication
7.4.1. Pneumonia
7.4.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
7.4.3. Sepsis
7.4.4. Tuberculosis
7.4.5. Dermatophytosis
7.4.6. Aspergillosis
7.4.7. Candidiasis
7.4.8. Hepatitis Virus Infection
7.4.9. HIV Infection
7.4.10. Respiratory Virus Infection
7.4.11. Others
7.5. Anti-infective Drugs Market Analysis, by Disease Indication
7.6. Anti-infective Drugs Market Attractiveness Analysis, by Disease Indication
7.7. Key Trends

8. Anti-infective Drugs Market Analysis, by Distribution Channel
8.1. Key Findings
8.2. Introduction
8.3. Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
8.4. Anti-infective Drugs Market Forecast, by Distribution Channel
8.4.1. Hospital Pharmacy
8.4.2. Retail Pharmacy
8.4.3. Online Sales
8.5. Anti-infective Drugs Market Analysis, by Distribution Channel
8.6. Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel
8.7. Market Trends

9. Anti-infective Drugs Market Analysis, by Region
9.1. Global Market Scenario
9.2. Anti-infective Drugs Market Value Share Analysis, by Region
9.3. Anti-infective Drugs Market Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Anti-infective Drugs Market Attractiveness Analysis, by Region

10. North America Anti-infective Drugs Market Analysis
10.1. Key Findings
10.2. North America Anti-infective Drugs Market Overview
10.3. North America Anti-infective Drugs Market Value Share Analysis, by Country
10.4. North America Anti-infective Drugs Market Forecast, by Country
10.4.1. U.S.
10.4.2. Canada
10.5. North America Anti-infective Drugs Market Value Share Analysis, by Type
10.6. North America Anti-infective Drugs Market Forecast, by Type
10.6.1. North America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-bacterial Drugs
10.6.2. North America Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
10.6.2.1. B - Lactams
10.6.2.2. Quinolones
10.6.2.3. Macrolides
10.6.2.4. Tetracycline
10.6.2.5. Aminoglycoside
10.6.2.6. Others (Sulfonamide, Phenicols)
10.6.3. North America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs
10.6.4. North America Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
10.6.4.1. Azoles
10.6.4.2. Echinocandins
10.6.4.3. Polyenes
10.6.4.4. Others
10.6.5. North America Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
10.7. North America Anti-infective Drugs Market Value Share Analysis, by Indication
10.8. North America Anti-infective Drugs Market Forecast, by Indication
10.8.1. Pneumonia
10.8.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
10.8.3. Sepsis
10.8.4. Tuberculosis
10.8.5. Dermatophytosis
10.8.6. Aspergillosis
10.8.7. Candidiasis
10.8.8. Hepatitis Virus Infection
10.8.9. HIV Infection
10.8.10. Respiratory Virus Infection
10.8.11. Others
10.9. North America Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
10.10. North America Anti-infective Drugs Market Forecast, by Distribution Channel
10.10.1. Hospital Pharmacy
10.10.2. Retail Pharmacy
10.10.3. Online Sales
10.11. North America Anti-infective Drugs Market Attractiveness Analysis

11. Europe Anti-infective Drugs Market Analysis
11.1. Key Findings
11.2. Europe Anti-infective Drugs Market Overview
11.3. Europe Anti-infective Drugs Market Value Share Analysis, by Country
11.4. Europe Anti-infective Drugs Market Forecast, by Country
11.4.1. U.K.
11.4.2. Germany
11.4.3. France
11.4.4. Italy
11.4.5. Spain
11.4.6. Rest of Europe
11.5. Europe Anti-infective Drugs Market Value Share Analysis, by Type
11.6. Europe Anti-infective Drugs Market Forecast, by Type
11.6.1. Europe Anti-infective Drugs Market Value Share Analysis, by Type - Anti-bacterial Drugs
11.6.2. Europe Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
11.6.2.1. B - Lactams
11.6.2.2. Quinolones
11.6.2.3. Macrolides
11.6.2.4. Tetracycline
11.6.2.5. Aminoglycoside
11.6.2.6. Others (Sulfonamide, Phenicols)
11.6.3. Europe Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs
11.6.4. Europe Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
11.6.4.1. Azoles
11.6.4.2. Echinocandins
11.6.4.3. Polyenes
11.6.4.4. Others
11.6.5.  Europe Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
11.7. Europe Anti-infective Drugs Market Value Share Analysis, by Indication
11.8. Europe Anti-infective Drugs Market Forecast, by Indication
11.8.1. Pneumonia
11.8.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
11.8.3. Sepsis
11.8.4. Tuberculosis
11.8.5. Dermatophytosis
11.8.6. Aspergillosis
11.8.7. Candidiasis
11.8.8. Hepatitis Virus Infection
11.8.9. HIV Infection
11.8.10. Respiratory Virus Infection
11.8.11. Others
11.9. Europe Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
11.10. Europe Anti-infective Drugs Market Forecast, by Distribution Channel
11.10.1. Hospital Pharmacy
11.10.2. Retail Pharmacy
11.10.3. Online Sales
11.11. Europe Anti-infective Drugs Market Attractiveness Analysis

12. Asia Pacific Anti-infective Drugs Market Analysis
12.1. Key Findings
12.2. Asia Pacific Anti-infective Drugs Market Overview
12.3. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Country
12.4. Asia Pacific rope Anti-infective Drugs Market Forecast, by Country
12.4.1. China
12.4.2. Japan
12.4.3. India
12.4.4. Australia & New Zealand
12.4.5. Rest of APAC
12.5. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Type
12.6. Asia Pacific Anti-infective Drugs Market Forecast, by Type
12.6.1. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Type - Anti-bacterial Drugs
12.6.2. Asia Pacific Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
12.6.2.1. B - Lactams
12.6.2.2. Quinolones
12.6.2.3. Macrolides
12.6.2.4. Tetracycline
12.6.2.5. Aminoglycoside
12.6.2.6. Others (Sulfonamide, Phenicols)
12.6.3. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs
12.6.4. Asia Pacific Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
12.6.4.1. Azoles
12.6.4.2. Echinocandins
12.6.4.3. Polyenes
12.6.4.4. Others
12.6.5.  Asia Pacific Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
12.7. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Indication
12.8. Asia Pacific Anti-infective Drugs Market Forecast, by Indication
12.8.1. Pneumonia
12.8.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
12.8.3. Sepsis
12.8.4. Tuberculosis
12.8.5. Dermatophytosis
12.8.6. Aspergillosis
12.8.7. Candidiasis
12.8.8. Hepatitis Virus Infection
12.8.9. HIV Infection
12.8.10. Respiratory Virus Infection
12.8.11. Others
12.9. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
12.10. Asia Pacific Anti-infective Drugs Market Forecast, by Distribution Channel
12.10.1. Hospital Pharmacy
12.10.2. Retail Pharmacy
12.10.3. Online Sales
12.11. Asia Pacific Anti-infective Drugs Market Attractiveness Analysis

13. Latin America Anti-infective Drugs Market Analysis
13.1. Key Findings
13.2. Latin America Anti-infective Drugs Market Overview
13.3. Latin America Anti-infective Drugs Market Value Share Analysis, by Country
13.4. Latin America Anti-infective Drugs Market Forecast, by Country
13.4.1. Brazil
13.4.2. Mexico
13.4.3. Rest of LATAM
13.5. Latin America Anti-infective Drugs Market Value Share Analysis, by Type
13.6. Latin America Anti-infective Drugs Market Forecast, by Type
13.6.1. Latin America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-bacterial Drugs
13.6.2. Latin America Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
13.6.2.1. B - Lactams
13.6.2.2. Quinolones
13.6.2.3. Macrolides
13.6.2.4. Tetracycline
13.6.2.5. Aminoglycoside
13.6.2.6. Others (Sulfonamide, Phenicols)
13.6.3. Latin America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs
13.6.4. Latin America Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
13.6.4.1. Azoles
13.6.4.2. Echinocandins
13.6.4.3. Polyenes
13.6.4.4. Others
13.6.5.  Latin America Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
13.7. Latin America Anti-infective Drugs Market Value Share Analysis, by Indication
13.8. Latin America Anti-infective Drugs Market Forecast, by Indication
13.8.1. Pneumonia
13.8.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
13.8.3. Sepsis
13.8.4. Tuberculosis
13.8.5. Dermatophytosis
13.8.6. Aspergillosis
13.8.7. Candidiasis
13.8.8. Hepatitis Virus Infection
13.8.9. HIV Infection
13.8.10. Respiratory Virus Infection
13.8.11. Others
13.9. Latin America Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
13.10. Latin America Anti-infective Drugs Market Forecast, by Distribution Channel
13.10.1. Hospital Pharmacy
13.10.2. Retail Pharmacy
13.10.3. Online Sales
13.11. Latin America Anti-infective Drugs Market Attractiveness Analysis

14. Middle East & Africa Anti-infective Drugs Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Anti-infective Drugs Market Overview
14.3. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Country
14.4. Middle East & Africa Anti-infective Drugs Market Forecast, by Country
14.4.1. GCC Countries
14.4.2. South Africa
14.4.3. Rest of MEA
14.5. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Type
14.6. Middle East & Africa Anti-infective Drugs Market Forecast, by Type
14.6.1. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Type - Anti-bacterial Drugs
14.6.2. Middle East & Africa Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
14.6.2.1. B - Lactams
14.6.2.2. Quinolones
14.6.2.3. Macrolides
14.6.2.4. Tetracycline
14.6.2.5. Aminoglycoside
14.6.2.6. Others (Sulfonamide, Phenicols)
14.6.3. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs
14.6.4. Middle East & Africa Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
14.6.4.1. Azoles
14.6.4.2. Echinocandins
14.6.4.3. Polyenes
14.6.4.4. Others
14.6.5.  Middle East & Africa Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
14.7. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Indication
14.8. Middle East & Africa Anti-infective Drugs Market Forecast, by Indication
14.8.1. Pneumonia
14.8.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
14.8.3. Sepsis
14.8.4. Tuberculosis
14.8.5. Dermatophytosis
14.8.6. Aspergillosis
14.8.7. Candidiasis
14.8.8. Hepatitis Virus Infection
14.8.9. HIV Infection
14.8.10. Respiratory Virus Infection
14.8.11. Others
14.9. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
14.9.1. Hospital Pharmacy
14.9.2. Retail Pharmacy
14.9.3. Online Sales
14.10. Middle East & Africa Anti-infective Drugs Market Forecast, by Distribution Channel
14.11. Middle East & Africa Anti-infective Drugs Market Attractiveness Analysis

15. Competition Matrix
15.1. Anti-infective Drugs Market Share Analysis, by Company, 2016
15.2. Company Profiles
15.2.1. Merck & Co., Inc.
15.2.1.1. Company Profiles
15.2.1.2. Business Overview
15.2.1.3. Strategic Overview
15.2.1.4. SWOT Analysis
15.3. Bayer AG
15.3.1.1. Company Profiles
15.3.1.2. Business Overview
15.3.1.3. Strategic Overview
15.3.1.4. SWOT Analysis
15.4. Pfizer, Inc.
15.4.1.1. Company Profiles
15.4.1.2. Business Overview
15.4.1.3. Strategic Overview
15.4.1.4. SWOT Analysis
15.5. Gilead Sciences
15.5.1.1. Company Profiles
15.5.1.2. Business Overview
15.5.1.3. Strategic Overview
15.5.1.4. SWOT Analysis
15.6. GlaxoSmithKline plc
15.6.1.1. Company Profiles
15.6.1.2. Business Overview
15.6.1.3. Strategic Overview
15.6.1.4. SWOT Analysis
15.7. Novartis AG
15.7.1.1. Company Profiles
15.7.1.2. Business Overview
15.7.1.3. Strategic Overview
15.7.1.4. SWOT Analysis
15.8. Bristol-Myers Squibb Co
15.8.1.1. Company Profiles
15.8.1.2. Business Overview
15.8.1.3. Strategic Overview
15.8.1.4. SWOT Analysis
15.9. Sanofi
15.9.1.1. Company Profiles
15.9.1.2. Business Overview
15.9.1.3. Strategic Overview
15.9.1.4. SWOT Analysis
15.10. Allergen plc
15.10.1.1. Company Profiles
15.10.1.2. Business Overview
15.10.1.3. Strategic Overview
15.10.1.4. SWOT Analysis
15.11. F. Hoffman-La Roche Ltd.
15.11.1.1. Company Profiles
15.11.1.2. Business Overview
15.11.1.3. Strategic Overview
15.11.1.4. SWOT Analysis
15.12. Johnson and Johnson
15.12.1.1. Company Profiles
15.12.1.2. Business Overview
15.12.1.3. Strategic Overview
15.12.1.4. SWOT Analysis

List of Table

Table 01: Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
Table 02: Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
Table 03: Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
Table 04: Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Disease Indication, 2017–2025
Table 05: Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
Table 06: Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Region, 2017–2025
Table 07: North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Country, 2017–2025
Table 08: North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
Table 09: North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
Table 10: North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
Table 10: North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Indication, 2017–2025
Table 12: North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
Table 13: Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Country, 2017–2025
Table 14: Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
Table 15: Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
Table 16: Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
Table 17: Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Indication, 2017–2025
Table 18: Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
Table 19: Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Country, 2017–2025
Table 20: Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
Table 21: Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
Table 22: Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
Table 23: Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Indication, 2017–2025
Table 24: Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
Table 25: Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Country, 2017–2025
Table 26: Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
Table 27: Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
Table 28: Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
Table 29: Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Indication, 2017–2025
Table 30: Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
Table 31: Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Country, 2017–2025
Table 32: Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
Table 33: Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
Table 34: Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
Table 35: Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Indication, 2017–2025
Table 36: Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025

List of Chart

Figure 01: Global Anti-infective Drugs Market Snapshot
Figure 02: Global Antiviral Drugs Market Size (US$ Mn) Forecast, 2017–2025
Figure 04: Market Value Share, by Type (2016)
Figure 06: Market Value Share, by Distribution Channel (2016)
Figure 03: Market Value Share, by Disease Indication (2016)
Figure 05: Market Value Share, by Region (2016)
Figure 07: Leading Antibacterial Drugs Sales Analysis, 2014–2016 
Figure 08: Leading Antiviral Drugs Sales Analysis, 2014–2016 
Figure 09: Global Anti-infective Drugs Market Value Share, by Product, 2016 and 2025
Figure 10: Global Anti-bacterial Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 10: Global Anti-fungal Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 12: Global Anti-viral Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 13: Anti-infective Drugs Market Attractiveness Analysis, by Type, 2017–2025
Figure 14: Global Anti-infective Drugs Market Value Share, by Disease Indication, 2016 and 2025
Figure 15: Global Pneumonia - Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 16: Global Methicillin-resistant Staphylococcus Aureus (MRSA) - Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 17: Global Sepsis Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 18: Global Tuberculosis Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 19: Global Dermatophytosis- Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 20: Global Aspergillosis -Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 21: Global Candidiasis -Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 22: Global Hepatitis Virus Infection -Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 23: Global HIV Infection -Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 24: Global Respiratory Virus Infection -Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 25: Global Others-Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 26: Anti-infective Drugs Market Attractiveness Analysis, by Disease Indication, 2017–2025
Figure 27: Global Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2025
Figure 28: Global Hospital Pharmacy Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 29: Global Retail Pharmacy Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 30: Global Online Pharmacy Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 31: Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 32: Global Anti-infective Drugs Market Value Share, by Region, 2016 and 2025
Figure 33: Anti-infective Drugs Market Attractiveness Analysis, by Region, 2017–2025
Figure 34: North America Anti-infective Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 35: North America Anti-infective Drugs Market Attractiveness Analysis, by Country, 2016–2025
Figure 36: North America Anti-infective Drugs Market Value Share Analysis, by Country, 2016 and 2025
Figure 37: North America Anti-infective Drugs Market Value Share Analysis, by Type, 2016 and 2025
Figure 38: North America Anti-infective Drugs Market Value Share Analysis, by Anti-bacterial Drugs, 2016 and 2025
Figure 39: North America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs, 2016 and 2025
Figure 40: North America Anti-infective Drugs Market Value Share Analysis, by Indication, 2016 and 2025
Figure 41: North America Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2025
Figure 42: North America Anti-infective Drugs Market Attractiveness Analysis, by Type, 2017–2025
Figure 43: North America Anti-infective Drugs Market Attractiveness Analysis, by Indication, 2017–2025
Figure 44: North America Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 45: Europe Anti-infective Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 46: Europe Anti-infective Drugs Market Attractiveness Analysis, by Country, 2016–2025
Figure 47: Europe Anti-infective Drugs Market Value Share Analysis, by Country, 2016 and 2025
Figure 48: Europe Anti-infective Drugs Market Value Share Analysis, by Type, 2016 and 2025
Figure 49: Europe Anti-infective Drugs Market Value Share Analysis, by Anti-bacterial Drugs, 2016 and 2025
Figure 50: Europe Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs, 2016 and 2025
Figure 51: Europe Anti-infective Drugs Market Value Share Analysis, by Indication, 2016 and 2025
Figure 52: Europe Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2025
Figure 53: Europe Anti-infective Drugs Market Attractiveness Analysis, by Type, 2016–2025
Figure 54: Europe Anti-infective Drugs Market Attractiveness Analysis, by Indication, 2016–2025
Figure 55: Europe Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2016–2025
Figure 56: Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 57: Asia Pacific Anti-infective Drugs Market Attractiveness Analysis, by Country, 2016–2025
Figure 58: Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Country, 2016 and 2025
Figure 59: Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Type, 2016 and 2025
Figure 60: Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Anti-bacterial Drugs, 2016 and 2025
Figure 61: Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs, 2016 and 2025
Figure 62: Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Indication, 2016 and 2025
Figure 63: Asia Pacific Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2025
Figure 64: Asia Pacific Anti-infective Drugs Market Attractiveness Analysis, by Type, 2017–2025
Figure 65: Asia Pacific Anti-infective Drugs Market Attractiveness Analysis, by Indication, 2017–2025
Figure 66: Asia Pacific Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 67: Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 68: Latin America Anti-infective Drugs Market Attractiveness Analysis, by Country, 2016–2025
Figure 69: Latin America Anti-infective Drugs Market Value Share Analysis, by Country, 2016 and 2025
Figure 70: Latin America Anti-infective Drugs Market Value Share Analysis, by Type, 2016 and 2025
Figure 71: Latin America Anti-infective Drugs Market Value Share Analysis, by Anti-bacterial Drugs, 2016 and 2025
Figure 72: Latin America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs, 2016 and 2025
Figure 73: Latin America Anti-infective Drugs Market Value Share Analysis, by Indication, 2016 and 2025
Figure 74: Latin America Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2024
Figure 75: Latin America Anti-infective Drugs Market Attractiveness Analysis, by Type, 2017–2025
Figure 76: Latin America Anti-infective Drugs Market Attractiveness Analysis, by Indication, 2017–2025
Figure 77: Latin America Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 78: Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 79: Middle East & Africa Anti-infective Drugs Market Attractiveness Analysis, by Country, 2016–2025
Figure 80: Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Country, 2016 and 2025
Figure 81: Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Type, 2016 and 2025
Figure 82: Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Anti-bacterial Drugs, 2016 and 2025
Figure 83: Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs, 2016 and 2025
Figure highlights market value share of the Anti-infective Drugs Market in Middle East & Africa, by Type –anti-fungal drugs, for 2016 and 2025
Figure 84: Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Indication, 2016 and 2025
Figure 85: Middle East & Africa Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2025
Figure 86: Middle East & Africa Anti-infective Drugs Market Attractiveness Analysis, by Type, 2017–2025
Figure 87: Middle East & Africa Anti-infective Drugs Market Attractiveness Analysis, by Indication, 2017–2025
Figure 88: Middle East & Africa Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *